From glycosylation disorders back to glycosylation: what have we learned?
Diseases of glycosylation have long remained confined to the rare hematological disorders, the Tn-syndrome and paroxysmal nocturnal hemoglobinuria. This rarity was often interpreted as a sign that defects of glycosylation are either lethal, or remain asymptomatic because of the large redundancy found in glycosylation pathways. The description of multiple glycosylation disorders over the last years has definitively settled the issue and demonstrated the broad range of biological processes relying on proper glycosylation. However, beyond establishing the developmental and physiological roles of glycosylation how did glycosylation disorders provided new insights to the field of glycobiology?
Hennet
Thierry
T
Institute of Physiology, University of Zürich, Switzerland. thennet@access.uzh.ch
D002239:Carbohydrate Metabolism, Inborn Errors / Q000150:complications* / Q000235:genetics; D018981:Congenital Disorders of Glycosylation / Q000150:complications / Q000235:genetics; D003569:Cytidine Monophosphate N-Acetylneuraminic Acid / Q000378:metabolism; D006031:Glycosylation; D006457:Hemoglobinuria, Paroxysmal / Q000209:etiology / Q000235:genetics; D006602:Hexosyltransferases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications; D008070:Lipopolysaccharides / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism
D008070:Lipopolysaccharides; D008565:Membrane Proteins; C023023:lipid-linked oligosaccharides; D003569:Cytidine Monophosphate N-Acetylneuraminic Acid; D006602:Hexosyltransferases; C025620:dolichyl-diphosphooligosaccharide - protein glycotransferase